Wilmington, Delaware, USA, Transparency Market Research Inc. – Dysmenorrhea is a medical term for pain experienced by women during the menstrual cycle. It refers to severe cramps felt in the lower abdomen which may extend to the back and lower legs.
Read the report overview – https://www.transparencymarketresearch.com/dysmenorrhea-treatment-market.html
The majority of women begin to experience severe pain in their early teens, around the first five years of the onset of the menstrual cycle. During menstruation, a mucous membrane forms around the uterus. This lining produces a chemical called prostaglandin. These prostaglandins are responsible for muscle contraction inside the uterus.
Muscle contraction causes pain and decreases the flow of oxygen and blood to the uterus. A wide range of underlying conditions can lead to menstrual disorders. To determine the root cause, doctors rely on the patient’s previous medical reports, lab tests, and physical exam. These tests help doctors determine the exact cause of dysmenorrhea and design an appropriate treatment plan.
Key Drivers and Opportunities of the Global Dysmenorrhea Treatment Market
Changing lifestyle, environmental changes and eating habits have had a significant impact on the human body. This has led to an increased incidence of dysmenorrhea in women. This is a major factor driving the global dysmenorrhea treatment market.
Request a report brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=70809
The increase in the incidence of dysmenorrhea has led to an increase in health awareness among women to fight the disease. Therefore, the adoption of drugs and drugs that help reduce pain during the menstrual cycle has increased. This in turn drives the growth of the global market.
Market companies have launched innovative drugs for the treatment of dysmenorrhea. Additionally, increase in government awareness campaigns on women’s health is fueling the growth of the global dysmenorrhea treatment market.
Major players are investing in research and development. This creates significant opportunities in the market. For example, in January 2021, Pfizer, Inc. and Myovant Sciences announced a positive Phase 3 mind-widening study of once-daily relugolix combination therapy in women with endometriosis. The therapy reported clinically significant reductions in dysmenorrhea. In September 2019, Bayer announced data demonstrating that a single nonprescription maximum dose of Aleve provided more pain relief over 12 hours than acetaminophen for menstrual cramps due to primary dysmenorrhea.
Request for ToC – https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=70809
North America to Dominate the Global Dysmenorrhea Treatment Market
In terms of region, the global dysmenorrhea treatment market can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global dysmenorrhea treatment market over the forecast period. Well-established healthcare infrastructure and high awareness are the factors likely to increase the market in the region.
The Asia-Pacific dysmenorrhea treatment market is expected to grow at a rapid rate during the forecast period. Rising purchasing power, increased awareness of clinical facilities, and improved infrastructure are likely to fuel the market growth in the region.
Key Players Operating in the Global Dysmenorrhea Treatment Market
The global dysmenorrhea treatment market is fragmented with the presence of international and local players. A large number of companies hold a large share in their respective regions. The growth strategies adopted by the major players are likely to boost the global market.
Inquire Before You Buy – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=70809
Leading players operating in the global Dysmenorrhea Treatment Market are:
- Bayer AG
- Taj Pharmaceuticals
- Novartis AG
- Mylan Pharmaceuticals
- F. Hoffmann-La Roche Ltd.
More trending reports by Transparency Market Research –
Biobank market: The biobank market is expected to grow at a CAGR of 5.9% during the forecast period of 2022 to 2031.
Brucellosis Vaccine Market: The global brucellosis vaccine market is expected to grow at a CAGR of 4% during the forecast period.
Solitary Fibrous Tumor Treatment Market: The solitary fibrous tumor treatment market is expected to grow at a modest CAGR of 4.5% during the forecast period.
Post Surgery Pain Therapies Market: The global market for postoperative pain treatments is expected to reach over US$22.3 billion by the end of 2031.
ACL Reconstruction Procedures Market: The ACL reconstruction procedures market is expected to mature from a revenue of US$6.8 billion in 2020 and reach US$11.5 billion by 2031.
CAR T Cell Therapy Market: The CAR T-cell therapy market is expected to register a CAGR of 30.6% during the assessment period.
Retinal Vein Occlusion Market: The retinal vein occlusion market is expected to exhibit a favorable CAGR of 7.3% during the forecast period.
Adrenocorticotropic Hormones Market: Global Adrenocorticotropic Hormone (ACTH) Market was valued at USD 1.3 Billion in 2020 and is projected to expand at a CAGR of 3.9% from 2021 to 2031.
Transparency Market Research, a global market research company registered in Wilmington, Delaware, USA, provides personalized research and consulting services. Our proprietary blend of quantitative forecasting and trend analysis provides forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.
For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453